mCRPC Care: Predicting Response to Radium-223 Treatment with a PET Scan

Here’s how a PET scan may be able to predict which patients with bone metastases from castration-resistant prostate cancer may respond to radium-223.

ReachMD Healthcare Image
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free